Shares of Bodycote plc (LON:BOY - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the six brokerages that are currently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is GBX 830.
Several analysts recently issued reports on BOY shares. JPMorgan Chase & Co. lifted their price target on shares of Bodycote from GBX 670 to GBX 700 and gave the company a "neutral" rating in a research report on Thursday, March 19th. Royal Bank Of Canada downgraded shares of Bodycote to a "sector perform" rating and set a GBX 775 price target for the company. in a research report on Thursday, March 12th. Jefferies Financial Group lifted their price target on shares of Bodycote from GBX 915 to GBX 925 and gave the company a "buy" rating in a research report on Monday, January 26th. Finally, Berenberg Bank reissued a "buy" rating and issued a GBX 900 price target on shares of Bodycote in a research report on Thursday, March 12th.
Check Out Our Latest Stock Analysis on Bodycote
Bodycote Stock Performance
LON BOY opened at GBX 668.04 on Wednesday. The company has a fifty day simple moving average of GBX 685.98 and a 200 day simple moving average of GBX 690.63. Bodycote has a 12-month low of GBX 493.80 and a 12-month high of GBX 800. The company has a current ratio of 1.15, a quick ratio of 0.74 and a debt-to-equity ratio of 29.80. The company has a market cap of £1.15 billion, a P/E ratio of 21.55, a PEG ratio of 1.44 and a beta of 1.34.
Bodycote (LON:BOY - Get Free Report) last posted its quarterly earnings results on Wednesday, March 11th. The company reported GBX 44.40 earnings per share (EPS) for the quarter. Bodycote had a net margin of 7.55% and a return on equity of 8.58%. Sell-side analysts predict that Bodycote will post 54.0540541 earnings per share for the current fiscal year.
About Bodycote
(
Get Free Report)
The leading provider of heat treatment and specialist thermal processing services worldwide.
Heat treatment encompasses a variety of techniques and specialist engineering processes which improve the properties of metals and alloys and extend the life of components and is a vital part of any manufacturing process.
Bodycote is uniquely placed via our global network and the experience and knowledge of our people to offer high quality, reliable and cost-effective services to manufacturers whatever their size or market sector.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bodycote, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bodycote wasn't on the list.
While Bodycote currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.